Metware Biotechnology Inc’s Post

#HighlyCitedPapers   📝 Mitochondrial Ca2+ Signaling and Bioenergetics in Alzheimer’s Disease — Arnst, et al.   In this paper, the authors focused on mitochondrial Ca2+ alterations in Alzheimer’s Disease (AD), their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca2+ signals to neuronal death in different experimental AD models.   Full text is available 👇 https://lnkd.in/g4NM6qKe   #medicine #health #research #science

Using genetic testing for diagnosing eye lateral view abnormalities has transformed the medical field, allowing for more accurate and efficient identification of conditions that impact vision and overall health. These abnormalities, affecting the side view of the eye, include issues with the optic nerve, retina, and eye muscles, and can be congenital or acquired later in life. Genetic testing provides early diagnosis, enables personalized treatment plans, and enhances understanding of these conditions, although challenges such as cost, accessibility, and ethical concerns exist. #GeneticTesting #EyeHealth #HealthcareInnovations #PersonalizedMedicine #EarlyDiagnosis Read more here: https://lnkd.in/ea4b6zMA BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

In this video, we delve into the fascinating world of chitinase 3 like protein 1 (CHI3L1) and its potential as a diagnostic tool for hepatic fibrosis. Hepatic fibrosis is a common liver disease that affects millions of people worldwide, but current diagnostic methods are often unreliable and invasive. That's where CHI3L1 comes in – recent research has shown that it may be a promising biomarker for hepatic fibrosis, offering a non-invasive and accurate way to diagnose and monitor the disease. Through our PowerPoint presentation, we'll explore the science behind CHI3L1 and hepatic fibrosis, examining the latest research and findings in the field. We'll cover topics such as the biology of CHI3L1, the mechanisms of hepatic fibrosis, and the potential clinical applications of CHI3L1 as a diagnostic tool. Our presentation is based on a thorough research paper, with insights and conclusions drawn from a variety of sources in the scientific community. Whether you're a medical professional, a researcher, or simply interested in the latest advances in biomedical science, this video is sure to provide you with valuable insights and knowledge. So sit back, relax, and join us on a journey through the exciting world of CHI3L1 and hepatic fibrosis diagnosis. #hepaticfibrosis #hepatitis #tumourmarkers #chitinase #HCC #liverdiseases #liverdisorders #referenceinterval #referencevalue #populationspecific #earlydiagnosis #noninvasivemarker #prevention #cure #Pakistan https://lnkd.in/ezCCtjmT

Re-review one of the most-cited 2022 PRS papers: “The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids” by Ogawa! Then explore other top trending papers for FREE: https://lnkd.in/eak7smrk #PlasticSurgery #Research #Science *** #HypertrophicScars and #keloids are fibroproliferative disorders that arise from abnormal wound healing. This literature review has summarized the latest medical developments in keloid and hypertrophic scar treatment and also suggests optimal treatment routes based on disease severity, ethnicity-based #genetic factors, and in case of recurrence. Read the article: https://lnkd.in/eDJet5bC

Diving deep into the cell's secrets – where every discovery brings us closer to victory over disease! Have you ever wondered why, despite our best efforts, some diseases remain stubbornly resistant to treatment? The answer may lie in the microscopic intricacies of cellular behavior, a puzzle that scientists are determined to solve. In the realm of medical research, understanding the mechanisms of disease resistance at the cellular level is akin to finding the missing piece of a complex puzzle. The study published in ScienceDirect tackles this head-on by delving into the cellular pathways that contribute to the resilience of certain diseases. This research is pivotal because it sheds light on why some conditions can outsmart even the most advanced treatments. By dissecting the cellular processes, scientists have identified potential targets for new drugs that could lead to more effective therapies for diseases that are currently hard to treat. But the work doesn't stop there. The findings from this study are a call to action for further research. There's a need for a concerted effort to translate these discoveries into tangible medical interventions that can improve patient outcomes. So, let's get the word out. This research has the potential to change lives, and it's crucial that it reaches as many people as possible. Because when we understand the enemy within, we can fight diseases more effectively. #MedicalMilestones #CellularBiology #DiseaseResistance #DrugDevelopment #HealthcareInnovation #ScienceCommunication #ResearchImpact #BreakthroughScience #UnderstandingDisease #HealthForAll

This correction addresses the study on senescence of human pancreatic beta cells and its effects on functional maturation and interferon responsiveness. The original article by Patra et al. highlighted how senescence could enhance beta cell function through chromatin reorganization and signaling pathways that promote interferon responsiveness in these cells. This correction likely clarifies specific points or errors in the original publication. #senescence #pancreaticbetacells #chromatinreorganization #interferonresponsiveness #correction Read more here: https://lnkd.in/eWAqn-uX BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

#RSCPoster #RSCAnalytical #Quality rather than Quantity ! Studying the quality of lipoproteins is proving to be a captivating and crucial field in biomedical research. These molecules, often considered mere carriers of lipids in the body, are emerging as true indicators of cardiovascular and metabolic health. Analyzing not only the quantity but also the composition and characteristics of lipoproteins provides a novel window into the complexity of physiological and pathological processes. In a world where cardiovascular and metabolic diseases are increasingly prevalent, understanding the quality of lipoproteins could pave the way for new diagnostic and therapeutic strategies, promoting a personalized approach to medicine and enhancing the overall health of the population.

Twin Health invented the Whole Body Digital Twin™ to help in remission, and improve and prevent chronic metabolic disease. Powered by artificial intelligence, the Whole Body Digital Twin™ is a dynamic representation of each individual’s metabolism. Everyone’s metabolism functions uniquely. The Whole Body Digital Twin™ continuously learns about each person and provides precise insights for improving health. Twin’s clinical research team is conducting the world’s first randomized controlled trial for remission of chronic metabolic disease using digital twin technology both in India and US; results include 94% of patients eliminating diabetes medications. Combining cutting-edge technology and advanced medical science, Twin Health addresses the root cause of metabolic disease. Explanation of why the project is worthy of the awa

🔬 Unveiling new insights into vascular calcification! Our latest article in @MDPIOpenAccess delves into the complex interplay of cellular and molecular mechanisms driving this condition. From ECs & VSMCs to critical signaling pathways. A pivotal read for professionals tackling cardiovascular diseases. 📖 Read more: https://lnkd.in/dqSfUf7V #VascularCalcification #CardiovascularResearch